Price $41.49 |
Market Cap
241.14B
|
Sector Health Care |
Div. Growth
4.10%
|
|
P/E
19.6
|
P/B
3.43
|
P/S
4.33
|
Dividend %
3.60%
|
|
P/CF
426.5
|
P/FCF
19.4
|
Op. Cash Flow
23.55M
|
FCF
2.2
|
|
Op. Margin
24.30%
|
Net Margin
23.80%
|
ROE
19.80%
|
ROI
7.60%
|
|
ROA
8.00%
|
EPS Growth
-7.40%
|
Current Ratio
1.4
|
Debt/Equity
58.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $6.84 | - | - | 284.5M | Strong Buy |
| Predictive Technology Group In (PRED) | $0.14 | - | - | 50.8M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.68 | - | - | 110.9M | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $2.41 | - | - | 15.9M | Strong Buy |
| Concert Pharmaceuticals Inc (CNCE) | $2.88 | - | - | 105.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
